Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Thursday, December 18, 2014 11:47:00 PM
Issuing many stocks early on makes the compensation appear smaller (becuz of low stock price), and it makes Brad owner of the shares faster (becuz of faster vesting).
Anyways, 18 million shares of Musclepharm in 2015 as predicted by bellator_exec is 100% nonsense.
Brad won't need anymore endorsers for quite a while. And issuing the remaining 1 million shares available for employees would be completely out of the question with the current stock price.
So most likely, at worst 30% of the approx. 1 million shares will be issued for employees next year. I doubt it though, with stock price below $9...I think it is more likely that the dilution will be close to 1% next year.
Brad is not going to raise capital next year sitting on 10% of the company. The stock price is simply too depressed for him to even consider that at this stage.
I wouldn't be surprised if intentions to acquire contract manufacturers was something that Musclepharm considered doing at some point over the next three years though.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM